The study aimed to evaluate the long-term efficacy and safety of vedolizumab in a real-life cohort of patients with inflammatory bowel diseases enrolled at a tertiary referral center.
Long-term efficacy and safety of vedolizumab in patients with inflammatory bowel diseases: A real-life experience from a tertiary referral center / Dragoni G.; Bagnoli S.; Le Grazie M.; Campani C.; Rogai F.; Manetti N.; Bensi C.; Macri G.; Galli A.; Milla M.. - In: JOURNAL OF DIGESTIVE DISEASES. - ISSN 1751-2972. - STAMPA. - 20:(2019), pp. 235-242. [10.1111/1751-2980.12748]
Long-term efficacy and safety of vedolizumab in patients with inflammatory bowel diseases: A real-life experience from a tertiary referral center
Campani C.;Galli A.;
2019
Abstract
The study aimed to evaluate the long-term efficacy and safety of vedolizumab in a real-life cohort of patients with inflammatory bowel diseases enrolled at a tertiary referral center.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
1751-2980.12748.pdf
accesso aperto
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Tutti i diritti riservati
Dimensione
1.05 MB
Formato
Adobe PDF
|
1.05 MB | Adobe PDF |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
